marbeta 25 kit

Generic: betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name marbeta 25 kit
Generic Name betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine
Labeler asclemed usa, inc.
Dosage Form KIT
Routes
EPIDURAL INFILTRATION INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR TOPICAL
Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-785
Product ID 76420-785_4803838b-2537-193d-e063-6294a90a426a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2027-12-31
Marketing Start 2010-04-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420785
Hyphenated Format 76420-785

Supplemental Identifiers

RxCUI
578803 797544 797730 1725078

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name marbeta 25 kit (source: ndc)
Generic Name betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine (source: ndc)
Routes
EPIDURAL INFILTRATION INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR TOPICAL
source: ndc

Resolved Composition

Strengths
  • 0.25 %
  • 25 mg/10 ml
  • 2.5 mg/ml
  • 75 mg/30 ml
  • 125 mg/50 ml
  • 0.5 %
  • 50 mg/10 ml
  • 5 mg/ml
  • 150 mg/30 ml
  • 250 mg/50 ml
  • 0.75 %
  • 75 mg/10 ml
  • 7.5 mg/ml
  • 225 mg/30 ml
  • 5 ml
  • 7.1 mg
  • 3.4 mg
  • 0.1 mg
  • 0.2 mg
  • 10 %
  • 9.85 %
  • 70 %
source: label
Packaging
  • 1 KIT in 1 CARTON (76420-785-01) * 10 mL in 1 VIAL, SINGLE-DOSE (0409-1159-18) * .9 mL in 1 PACKET (67777-419-02) * 5 mL in 1 POUCH * 1 VIAL, MULTI-DOSE in 1 CARTON (0517-0720-01) / 5 mL in 1 VIAL, MULTI-DOSE
source: ndc

Packages (1)

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["EPIDURAL", "INFILTRATION", "INTRA-ARTICULAR", "INTRALESIONAL", "INTRAMUSCULAR", "TOPICAL"], "spl_id": "4803838b-2537-193d-e063-6294a90a426a", "openfda": {"rxcui": ["578803", "797544", "797730", "1725078"], "spl_set_id": ["1c157964-1977-4617-9f01-76ca01fb0f8f"], "manufacturer_name": ["Asclemed USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 CARTON (76420-785-01)  *  10 mL in 1 VIAL, SINGLE-DOSE (0409-1159-18)  *  .9 mL in 1 PACKET (67777-419-02)  *  5 mL in 1 POUCH *  1 VIAL, MULTI-DOSE in 1 CARTON (0517-0720-01)  / 5 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "76420-785-01", "marketing_start_date": "20160523"}], "brand_name": "Marbeta 25 Kit", "product_id": "76420-785_4803838b-2537-193d-e063-6294a90a426a", "dosage_form": "KIT", "product_ndc": "76420-785", "generic_name": "Betamethasone Sodium Phosphate and Betamethasone Acetate, Bupivacaine Hydrochloride, Povidine Iodine", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Marbeta 25 Kit", "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20100428", "listing_expiration_date": "20271231"}